持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/13 | 3,330 | 3,345 | 3,295 | 3,300 | -55 | -1.6% | 47,600 |
| 2023/06/12 | 3,335 | 3,360 | 3,315 | 3,355 | +20 | +0.6% | 25,600 |
| 2023/06/09 | 3,305 | 3,355 | 3,305 | 3,335 | +30 | +0.9% | 44,000 |
| 2023/06/08 | 3,335 | 3,350 | 3,285 | 3,305 | -30 | -0.9% | 45,500 |
| 2023/06/07 | 3,365 | 3,405 | 3,335 | 3,335 | -5 | -0.1% | 54,500 |
| 2023/06/06 | 3,325 | 3,355 | 3,295 | 3,340 | -15 | -0.4% | 39,900 |
| 2023/06/05 | 3,420 | 3,435 | 3,335 | 3,355 | -5 | -0.1% | 40,600 |
| 2023/06/02 | 3,330 | 3,370 | 3,330 | 3,360 | +25 | +0.7% | 23,900 |
| 2023/06/01 | 3,345 | 3,395 | 3,325 | 3,335 | +45 | +1.4% | 42,400 |
| 2023/05/31 | 3,350 | 3,360 | 3,290 | 3,290 | -110 | -3.2% | 68,700 |
| 2023/05/30 | 3,435 | 3,455 | 3,380 | 3,400 | -55 | -1.6% | 21,400 |
| 2023/05/29 | 3,490 | 3,490 | 3,435 | 3,455 | +10 | +0.3% | 24,000 |
| 2023/05/26 | 3,540 | 3,540 | 3,420 | 3,445 | -75 | -2.1% | 45,700 |
| 2023/05/25 | 3,520 | 3,560 | 3,510 | 3,520 | -65 | -1.8% | 31,900 |
| 2023/05/24 | 3,600 | 3,625 | 3,580 | 3,585 | -35 | -1% | 21,100 |
| 2023/05/23 | 3,670 | 3,675 | 3,605 | 3,620 | -35 | -1% | 31,000 |
| 2023/05/22 | 3,585 | 3,655 | 3,585 | 3,655 | +25 | +0.7% | 23,900 |
| 2023/05/19 | 3,660 | 3,665 | 3,625 | 3,630 | -15 | -0.4% | 23,700 |
| 2023/05/18 | 3,690 | 3,695 | 3,615 | 3,645 | -55 | -1.5% | 31,900 |
| 2023/05/17 | 3,700 | 3,720 | 3,655 | 3,700 | -40 | -1.1% | 40,200 |
| 2023/05/16 | 3,660 | 3,745 | 3,660 | 3,740 | +150 | +4.2% | 51,600 |
| 2023/05/15 | 3,605 | 3,645 | 3,575 | 3,590 | -10 | -0.3% | 59,200 |
| 2023/05/12 | 3,565 | 3,610 | 3,540 | 3,600 | +50 | +1.4% | 37,000 |
| 2023/05/11 | 3,510 | 3,575 | 3,510 | 3,550 | +5 | +0.1% | 25,300 |
| 2023/05/10 | 3,580 | 3,585 | 3,540 | 3,545 | -30 | -0.8% | 22,200 |
| 2023/05/09 | 3,550 | 3,580 | 3,540 | 3,575 | +70 | +2% | 33,900 |
| 2023/05/08 | 3,480 | 3,530 | 3,480 | 3,505 | +25 | +0.7% | 17,500 |
| 2023/05/02 | 3,540 | 3,545 | 3,470 | 3,480 | -30 | -0.9% | 16,300 |
| 2023/05/01 | 3,500 | 3,515 | 3,480 | 3,510 | +30 | +0.9% | 27,500 |
| 2023/04/28 | 3,455 | 3,510 | 3,450 | 3,480 | +60 | +1.8% | 31,000 |
| 2023/04/27 | 3,405 | 3,435 | 3,385 | 3,420 | ±0 | ±0% | 87,900 |
| 2023/04/26 | 3,465 | 3,465 | 3,410 | 3,420 | -60 | -1.7% | 25,400 |
| 2023/04/25 | 3,460 | 3,510 | 3,460 | 3,480 | +30 | +0.9% | 24,000 |
| 2023/04/24 | 3,475 | 3,510 | 3,445 | 3,450 | -25 | -0.7% | 20,000 |
| 2023/04/21 | 3,470 | 3,500 | 3,450 | 3,475 | -5 | -0.1% | 17,000 |
| 2023/04/20 | 3,415 | 3,495 | 3,415 | 3,480 | +40 | +1.2% | 31,700 |
| 2023/04/19 | 3,470 | 3,470 | 3,410 | 3,440 | -30 | -0.9% | 25,600 |
| 2023/04/18 | 3,470 | 3,495 | 3,465 | 3,470 | +15 | +0.4% | 27,300 |
| 2023/04/17 | 3,475 | 3,490 | 3,425 | 3,455 | -40 | -1.1% | 21,700 |
| 2023/04/14 | 3,425 | 3,495 | 3,425 | 3,495 | +85 | +2.5% | 34,900 |
| 2023/04/13 | 3,365 | 3,445 | 3,365 | 3,410 | +15 | +0.4% | 23,400 |
| 2023/04/12 | 3,350 | 3,400 | 3,350 | 3,395 | +45 | +1.3% | 23,600 |
| 2023/04/11 | 3,315 | 3,360 | 3,305 | 3,350 | +50 | +1.5% | 38,400 |
| 2023/04/10 | 3,290 | 3,300 | 3,265 | 3,300 | +30 | +0.9% | 33,000 |
| 2023/04/07 | 3,250 | 3,285 | 3,250 | 3,270 | ±0 | ±0% | 23,100 |
| 2023/04/06 | 3,245 | 3,280 | 3,240 | 3,270 | -5 | -0.2% | 38,300 |
| 2023/04/05 | 3,345 | 3,345 | 3,275 | 3,275 | -100 | -3% | 32,500 |
| 2023/04/04 | 3,370 | 3,395 | 3,340 | 3,375 | +30 | +0.9% | 32,400 |
| 2023/04/03 | 3,365 | 3,405 | 3,335 | 3,345 | +5 | +0.1% | 35,500 |
| 2023/03/31 | 3,325 | 3,365 | 3,320 | 3,340 | +35 | +1.1% | 29,000 |
451～
500
件表示中 / 3680件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 294,900円 | +3.0% | +27.5% | 2.71% | 18.66倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 鳥居薬 | 426,000円 | +7.1% | -35.0% | 2.82% | 35.22倍 | 0.98倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 223,300円 | +14.2% | +41.0% | 2.06% | 10.94倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 143,800円 | +3.2% | +4.5% | 3.62% | 16.52倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ジーエヌアイ | 180,100円 | +21.7% | +999.9% | 0.00% | 7.50倍 | 2.48倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
